I promise

"I promise, Suzy... Even if it takes the rest of my life." -Nancy G. Brinker, Founder of Susan G. Komen for the Cure

What is TNBC

WHAT IS TRIPLE NEGATIVE BREAST CANCER?

Just in recent years, Triple Negative Breast Cancer (TNBC) has sparked interest in the news where instead of calling the tumor as ER-negative, PR-negative, and HER2-negative; researchers began using the shorthand term, "Triple Negative," dubbed the "new type" of breast cancer. Being Triple Negative, you don't have a targeted therapy and your only treatment option is chemotherapy.

Triple Negative Breast Cancer is seen in about 15% of all breast cancers. TNBC is a very aggressive cancer that tends to strike younger women, pre-menopause, especially among African-American women and women who have BRCA1 mutations. The tumor tends to be fast growing and is less likely to show up on an annual mammogram. TNBC is more likely to metastasis early on; has a high rate of recurrence in the first 2-3 years from diagnosis and has a poorer prognosis than other types of breast cancer due to lack of specific, targeted treatment for TNBC.

Thursday, April 16, 2015

Toledo Area Oncologist, Dr. Iman Mohamed Honored with the YWCA Science Milestone Award

My amazing oncologist, Dr. Iman Mohamed was recognized with the YWCA of Northwest Ohio, Science Milestone Award. Dr. Mohamed was honored for her outreach programs focusing on bringing awareness to breast cancer through education and preventative care. Dr. Mohamed commitment to education, research and dedication to her patients was also recognized.
Congratulations Dr. Mohamed, such a great honor!

 (Click link to full story)
UT News » Blog Archive » Professor, trustee recognized for service, achievement


Posted by
Labels:

Total Pageviews



"click image to link"